Cargando…

Emerging Role of Sirtuin 2 in Parkinson’s Disease

Parkinson’s disease (PD), the main risk factor of which is age, is one of the most common neurodegenerative diseases, thus presenting a substantial burden on the health of affected individuals as well as an economic burden. Sirtuin 2 (SIRT2), a subtype in the family of sirtuins, belongs to class III...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yumei, Zhang, Yingying, Zhu, Konghua, Chi, Song, Wang, Chong, Xie, Anmu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965030/ https://www.ncbi.nlm.nih.gov/pubmed/31998119 http://dx.doi.org/10.3389/fnagi.2019.00372

Ejemplares similares

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
por: Yang, Liying, et al.
Publicado: (2018)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

The role of sirtuins in Alzheimer's disease
por: Lalla, Rakhee, et al.
Publicado: (2013)

Associations of Sleep Disorders With Depressive Symptoms in Early and Prodromal Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2022)

The Emerging Role of Neuropeptides in Parkinson’s Disease
por: Zheng, Yanan, et al.
Publicado: (2021)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

RAGE Silencing Ameliorates Neuroinflammation by Inhibition of p38-NF-κB Signaling Pathway in Mouse Model of Parkinson’s Disease
por: Wang, Xiaoli, et al.
Publicado: (2020)

Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
por: Dou, Kaixin, et al.
Publicado: (2022)

Role of Sirtuins in Linking Metabolic Syndrome with Depression
por: Song, Juhyun, et al.
Publicado: (2016)

The emerging role of circular RNAs in Parkinson’s disease
por: Liao, Jiajia, et al.
Publicado: (2023)

Clinical characteristics in early Parkinson's disease with excessive daytime sleepiness: A cross‐sectional and longitudinal study
por: Liu, Yumei, et al.
Publicado: (2023)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

Sirtuin 2 (SIRT2): Confusing Roles in the Pathophysiology of Neurological Disorders
por: Chen, Xiuqi, et al.
Publicado: (2021)

The Emerging Role of Circular RNAs in Alzheimer’s Disease and Parkinson’s Disease
por: Zhang, Meng, et al.
Publicado: (2021)

Sirtuins in Neuroendocrine Regulation and Neurological Diseases
por: Fujita, Yuki, et al.
Publicado: (2018)

Determinants of diagnostic latency in Chinese people with Parkinson’s disease
por: Wan, Ying, et al.
Publicado: (2019)

The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
por: Vazey, Elena M., et al.
Publicado: (2012)

Improvement of Subthalamic Nucleus Deep Brain Stimulation in Sleeping Symptoms in Parkinson's Disease: A Meta-Analysis
por: Zhang, Xue, et al.
Publicado: (2019)

Sirtuins in neurodegenerative diseases: an update on potential mechanisms
por: Min, Sang-Won, et al.
Publicado: (2013)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
por: Błaszczyk, Janusz W.
Publicado: (2018)

Sirtuins: New Roles for Sirtuins in Aging and Disease
por: Chua, Katrin
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Editorial on Special Topic: Sirtuins in Metabolism, Aging, and Disease
por: Kazantsev, Aleksey G., et al.
Publicado: (2012)

P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD
por: Ma, Jiangnan, et al.
Publicado: (2020)

Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis
por: Wang, Ying, et al.
Publicado: (2018)

Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
por: Yang, Qianjie, et al.
Publicado: (2020)

Role of Sirtuins in Modulating Neurodegeneration of the Enteric Nervous System and Central Nervous System
por: Chandramowlishwaran, Pavithra, et al.
Publicado: (2020)

Emerging Treatment Approaches for Parkinson’s Disease
por: Stoker, Thomas B., et al.
Publicado: (2018)

Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson’s mouse model
por: Weng, Huidan, et al.
Publicado: (2023)

Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders?
por: Fan, Zhang, et al.
Publicado: (2022)

Emerging beneficial roles of sirtuins in heart failure
por: Tanno, Masaya, et al.
Publicado: (2012)

Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
por: Silberman, Dafne M.
Publicado: (2018)

Emerging Evidence concerning the Role of Sirtuins in Sepsis
por: Li, Lulan, et al.
Publicado: (2018)

Stability Evaluation of Brain Changes in Parkinson's Disease Based on Machine Learning
por: Song, Chenggang, et al.
Publicado: (2021)

Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases
por: Wan, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4noul67lgbmp9pj9f0qgp36301